Fortis Healthcare shares reached an all-time high of Rs 976.65 on the BSE in the opening trade, rising nearly 1% from the previous close. Fortis Healthcare is included as one of the stocks in the Nifty Midcap 150 index.
The company's consolidated financial performance shows steady growth. Revenue for the quarter-ending June 2025 stood at Rs 2,166.72 Crore, up from Rs 1,858.90 Crore in June 2024. Net profit for the same period was Rs 263.86 Crore, compared to Rs 173.39 Crore in the previous year. The EPS increased to Rs 3.45 in June 2025 from Rs 2.20 in June 2024.
Here's a more detailed look at the company's consolidated quarterly financials:
| Heading | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|
| Sales | Rs 2,166 Crore | Rs 2,007 Crore | Rs 1,928 Crore | Rs 1,988 Crore | Rs 1,858 Crore |
| Other Income | Rs 15 Crore | Rs 19 Crore | Rs 20 Crore | Rs 13 Crore | Rs 13 Crore |
| Total Income | Rs 2,182 Crore | Rs 2,027 Crore | Rs 1,949 Crore | Rs 2,001 Crore | Rs 1,871 Crore |
| Total Expenditure | Rs 1,764 Crore | Rs 1,727 Crore | Rs 1,626 Crore | Rs 1,708 Crore | Rs 1,607 Crore |
| EBIT | Rs 417 Crore | Rs 299 Crore | Rs 322 Crore | Rs 293 Crore | Rs 264 Crore |
| Interest | Rs 69 Crore | Rs 67 Crore | Rs 45 Crore | Rs 36 Crore | Rs 35 Crore |
| Tax | Rs 83 Crore | Rs 48 Crore | Rs 25 Crore | Rs 67 Crore | Rs 56 Crore |
| Net Profit | Rs 263 Crore | Rs 183 Crore | Rs 252 Crore | Rs 188 Crore | Rs 173 Crore |
The company's annual financial data indicates consistent growth. Revenue increased from Rs 4,030.12 Crore in 2021 to Rs 7,782.75 Crore in 2025. Net profit also saw a significant rise from a loss of Rs -103.73 Crore in 2021 to a profit of Rs 797.86 Crore in 2025.
Here’s a summary of the consolidated yearly financials:
| Heading | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|
| Sales | Rs 7,782 Crore | Rs 6,892 Crore | Rs 6,297 Crore | Rs 5,717 Crore | Rs 4,030 Crore |
| Other Income | Rs 66 Crore | Rs 38 Crore | Rs 61 Crore | Rs 27 Crore | Rs 46 Crore |
| Total Income | Rs 7,849 Crore | Rs 6,931 Crore | Rs 6,359 Crore | Rs 5,744 Crore | Rs 4,076 Crore |
| Total Expenditure | Rs 6,669 Crore | Rs 5,951 Crore | Rs 5,438 Crore | Rs 4,634 Crore | Rs 3,915 Crore |
| EBIT | Rs 1,179 Crore | Rs 979 Crore | Rs 920 Crore | Rs 1,110 Crore | Rs 161 Crore |
| Interest | Rs 184 Crore | Rs 130 Crore | Rs 129 Crore | Rs 146 Crore | Rs 165 Crore |
| Tax | Rs 197 Crore | Rs 212 Crore | Rs 180 Crore | Rs 197 Crore | Rs 99 Crore |
| Net Profit | Rs 797 Crore | Rs 635 Crore | Rs 611 Crore | Rs 765 Crore | Rs -103 Crore |
Key financial ratios for Fortis Healthcare as of March 2025 include a basic EPS of Rs 10.26, a book value per share of Rs 118.11, and a dividend per share of Rs 1.00. The company’s debt to equity ratio is 0.25, and the interest coverage ratio is 8.97.
The company announced a change in directorate with the appointment of Dr. Keith and the resignation of Mr. Tomo Nagahiro, effective September 9, 2025. The company also announced a final dividend of Rs 1.00 per share on May 20, 2025, with an effective date of July 25, 2025.
Based on Moneycontrol analysis, investor sentiment is very bullish. Fortis Healthcare has demonstrated strong financial performance and positive investor sentiment.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
